<DOC>
	<DOCNO>NCT01984554</DOCNO>
	<brief_summary>The primary objective study compare total cost sit payer administer IV iron 30-day observation period subject IDA receive Ferric Carboxymaltose ( FCM ) relative receive iron sucrose , iron dextran , ferumoxytol .</brief_summary>
	<brief_title>Observational Study Use IV ( Intravenous ) Iron Therapy Among Subjects With Iron Deficiency Anemia</brief_title>
	<detailed_description>The primary objective study compare total cost sit payer administer IV iron 30-day observation period subject IDA receive Ferric Carboxymaltose ( FCM ) relative receive iron sucrose , iron dextran , ferumoxytol .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Must present first dose current cycle IV treatment IDA Must 18 year age Must willing able provide inform consent , include permission obtain information medical record . Must able read understand English . Subjects diagnose IDA . Subjects require one treatment cycle within 30 day . Subjects receive maintenance IV iron therapy . Subjects treat IV iron within 30day period prior study enrollment . Subjects received investigational medication six month prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>